Literature DB >> 18042691

Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

M-Q Du1, C M Bacon, P G Isaacson.   

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), is a recent addition to the list of human viruses that are directly associated with lymphoproliferative disorders. KSHV was first shown to be involved in multicentric Castleman disease and primary effusion lymphoma (PEL). Subsequently, the virus was identified in solid lymphomas, often of extranodal sites, with morphological and immunophenotypic characteristics similar to those of PEL, and in other lymphoproliferative disorders with heterogeneous clinicopathological presentations. The recent advances in our understanding of the histology, immunophenotype and pathogenesis of these KSHV-associated lymphoproliferative disorders are reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042691      PMCID: PMC2095558          DOI: 10.1136/jcp.2007.047969

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  110 in total

Review 1.  Regulation of KSHV lytic gene expression.

Authors:  H Deng; Y Liang; R Sun
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

2.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.

Authors:  Huaxin Si; Erle S Robertson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  KSHV- and EBV-associated germinotropic lymphoproliferative disorder.

Authors:  Ming-Qing Du; Tim C Diss; Hongxiang Liu; Hongtao Ye; Rifat A Hamoudi; José Cabeçadas; Henry Y Dong; Nancy Lee Harris; John K C Chan; John W Rees; Ahmet Dogan; Peter G Isaacson
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

4.  KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.

Authors:  Grzegorz Sarek; Annika Järviluoma; Päivi M Ojala
Journal:  Blood       Date:  2005-09-13       Impact factor: 22.113

Review 5.  Serous effusions in malignant lymphomas: a review.

Authors:  Dilip K Das
Journal:  Diagn Cytopathol       Date:  2006-05       Impact factor: 1.582

6.  NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.

Authors:  Shannon A Keller; Denise Hernandez-Hopkins; Jelena Vider; Vladimir Ponomarev; Elizabeth Hyjek; Elaine J Schattner; Ethel Cesarman
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

Review 7.  Structure and function of latency-associated nuclear antigen.

Authors:  S C Verma; K Lan; E Robertson
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

8.  Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

Authors:  Ulf Klein; Annunziata Gloghini; Gianluca Gaidano; Amy Chadburn; Ethel Cesarman; Riccardo Dalla-Favera; Antonino Carbone
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

9.  The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.

Authors:  Farnaz D Fakhari; Joseph H Jeong; Yogita Kanan; Dirk P Dittmer
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

10.  The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.

Authors:  Alexander Golks; Dirk Brenner; Peter H Krammer; Inna N Lavrik
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

View more
  29 in total

1.  18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.

Authors:  Francesco Bertagna; Giorgio Biasiotto; Rosita Rodella; Raffaele Giubbini; Abass Alavi
Journal:  Jpn J Radiol       Date:  2010-05-01       Impact factor: 2.374

2.  Kaposi's sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation.

Authors:  Qiming Liang; Brian Chang; Kevin F Brulois; Kamilah Castro; Chan-Ki Min; Mary A Rodgers; Mude Shi; Jianning Ge; Pinghui Feng; Byung-Ha Oh; Jae U Jung
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.

Authors:  Kevin F Brulois; Heesoon Chang; Amy Si-Ying Lee; Armin Ensser; Lai-Yee Wong; Zsolt Toth; Sun Hwa Lee; Hye-Ra Lee; Jinjong Myoung; Don Ganem; Tae-Kwang Oh; Jihyun F Kim; Shou-Jiang Gao; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 4.  Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?

Authors:  Henry F Vischer; Marco Siderius; Rob Leurs; Martine J Smit
Journal:  Nat Rev Drug Discov       Date:  2014-01-21       Impact factor: 84.694

Review 5.  New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA.

Authors:  Nicholas K Conrad
Journal:  Virus Res       Date:  2015-06-21       Impact factor: 3.303

6.  Castleman's disease of a submandibular mass diagnosed on Fine Needle Cytology: Report of a case with histopathological, immunocytochemical and imaging correlations.

Authors:  Maria Gabriella Malzone; Anna Cipolletta Campanile; Veronica Sanna; Franco Ionna; Francesco Longo; Annarosaria De Chiara; Sergio Venanzio Setola; Gerardo Botti; Franco Fulciniti
Journal:  Intractable Rare Dis Res       Date:  2016-02

Review 7.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

8.  EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.

Authors:  Lynnette K Tumwine; Jackson Orem; Patrick Kerchan; Wilson Byarugaba; Stefano A Pileri
Journal:  Infect Agent Cancer       Date:  2010-06-30       Impact factor: 2.965

9.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

Authors:  Donald C Vinh; Smita Y Patel; Gulbu Uzel; Victoria L Anderson; Alexandra F Freeman; Kenneth N Olivier; Christine Spalding; Stephen Hughes; Stefania Pittaluga; Mark Raffeld; Lynn R Sorbara; Houda Z Elloumi; Douglas B Kuhns; Maria L Turner; Edward W Cowen; Danielle Fink; Debra Long-Priel; Amy P Hsu; Li Ding; Michelle L Paulson; Adeline R Whitney; Elizabeth P Sampaio; David M Frucht; Frank R DeLeo; Steven M Holland
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

10.  View and review on viral oncology research.

Authors:  Valeria Bergonzini; Cristiano Salata; Arianna Calistri; Cristina Parolin; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2010-05-24       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.